T2 BIOSYSTEMS INC (TTOO) Fundamental Analysis & Valuation

NASDAQ:TTOO • US89853L3024

Current stock price

0.134 USD
-0.06 (-31.07%)
At close:
0.12 USD
-0.01 (-10.45%)
After Hours:

This TTOO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TTOO Profitability Analysis

1.1 Basic Checks

  • TTOO had negative earnings in the past year.
  • TTOO had a negative operating cash flow in the past year.
  • TTOO had negative earnings in each of the past 5 years.
  • In the past 5 years TTOO always reported negative operating cash flow.
TTOO Yearly Net Income VS EBIT VS OCF VS FCFTTOO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

  • TTOO's Return On Assets of -237.55% is on the low side compared to the rest of the industry. TTOO is outperformed by 92.36% of its industry peers.
Industry RankSector Rank
ROA -237.55%
ROE N/A
ROIC N/A
ROA(3y)-135.6%
ROA(5y)-134.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TTOO Yearly ROA, ROE, ROICTTOO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

1.3 Margins

  • TTOO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TTOO Yearly Profit, Operating, Gross MarginsTTOO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. TTOO Health Analysis

2.1 Basic Checks

  • TTOO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TTOO has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for TTOO has been reduced compared to a year ago.
TTOO Yearly Shares OutstandingTTOO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
TTOO Yearly Total Debt VS Total AssetsTTOO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -55.84, we must say that TTOO is in the distress zone and has some risk of bankruptcy.
  • TTOO's Altman-Z score of -55.84 is on the low side compared to the rest of the industry. TTOO is outperformed by 95.03% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -55.84
ROIC/WACCN/A
WACC7.42%
TTOO Yearly LT Debt VS Equity VS FCFTTOO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

2.3 Liquidity

  • A Current Ratio of 0.40 indicates that TTOO may have some problems paying its short term obligations.
  • With a Current ratio value of 0.40, TTOO is not doing good in the industry: 94.49% of the companies in the same industry are doing better.
  • TTOO has a Quick Ratio of 0.40. This is a bad value and indicates that TTOO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.24, TTOO is doing worse than 96.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.24
TTOO Yearly Current Assets VS Current LiabilitesTTOO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TTOO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.25% over the past year.
  • TTOO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.16%.
  • Measured over the past years, TTOO shows a decrease in Revenue. The Revenue has been decreasing by -7.29% on average per year.
EPS 1Y (TTM)97.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.59%
Revenue 1Y (TTM)-30.16%
Revenue growth 3Y-26.52%
Revenue growth 5Y-7.29%
Sales Q2Q%34.85%

3.2 Future

  • TTOO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.64% yearly.
  • TTOO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 54.19% yearly.
EPS Next Y83.26%
EPS Next 2Y39.13%
EPS Next 3Y25.19%
EPS Next 5Y14.64%
Revenue Next Year51.43%
Revenue Next 2Y81.66%
Revenue Next 3Y68.18%
Revenue Next 5Y54.19%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TTOO Yearly Revenue VS EstimatesTTOO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
TTOO Yearly EPS VS EstimatesTTOO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -2K -4K -6K -8K -10K

More info and screens

Find the best growth stocksShow best growing peers

1

4. TTOO Valuation Analysis

4.1 Price/Earnings Ratio

  • TTOO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TTOO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TTOO Price Earnings VS Forward Price EarningsTTOO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TTOO Per share dataTTOO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • TTOO's earnings are expected to grow with 25.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.13%
EPS Next 3Y25.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TTOO Dividend Analysis

5.1 Amount

  • TTOO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

TTOO Fundamentals: All Metrics, Ratios and Statistics

T2 BIOSYSTEMS INC

NASDAQ:TTOO (2/11/2025, 8:00:01 PM)

After market: 0.12 -0.01 (-10.45%)

0.134

-0.06 (-31.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-13
Earnings (Next)05-05
Inst Owners3.18%
Inst Owner Change900%
Ins Owners0.1%
Ins Owner Change0%
Market Cap3.76M
Revenue(TTM)7.68M
Net Income(TTM)-42.95M
Analysts43.33
Price Target5.1 (3705.97%)
Short Float %0.03%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.68%
Min Revenue beat(2)-30.5%
Max Revenue beat(2)-8.87%
Revenue beat(4)1
Avg Revenue beat(4)-7.69%
Min Revenue beat(4)-30.5%
Max Revenue beat(4)26.29%
Revenue beat(8)1
Avg Revenue beat(8)-6.63%
Revenue beat(12)3
Avg Revenue beat(12)-6.67%
Revenue beat(16)6
Avg Revenue beat(16)-2.71%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.82
EYN/A
EPS(NY)-1.21
Fwd EYN/A
FCF(TTM)-1.31
FCFYN/A
OCF(TTM)-1.3
OCFYN/A
SpS0.27
BVpS-0.42
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -237.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-135.6%
ROA(5y)-134.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.24
Altman-Z -55.84
F-Score3
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)30.32%
Cap/Depr(5y)34.46%
Cap/Sales(3y)1.94%
Cap/Sales(5y)3.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.59%
EPS Next Y83.26%
EPS Next 2Y39.13%
EPS Next 3Y25.19%
EPS Next 5Y14.64%
Revenue 1Y (TTM)-30.16%
Revenue growth 3Y-26.52%
Revenue growth 5Y-7.29%
Sales Q2Q%34.85%
Revenue Next Year51.43%
Revenue Next 2Y81.66%
Revenue Next 3Y68.18%
Revenue Next 5Y54.19%
EBIT growth 1Y12.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.02%
OCF growth 3YN/A
OCF growth 5YN/A

T2 BIOSYSTEMS INC / TTOO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for T2 BIOSYSTEMS INC?

ChartMill assigns a fundamental rating of 1 / 10 to TTOO.


Can you provide the valuation status for T2 BIOSYSTEMS INC?

ChartMill assigns a valuation rating of 1 / 10 to T2 BIOSYSTEMS INC (TTOO). This can be considered as Overvalued.


How profitable is T2 BIOSYSTEMS INC (TTOO) stock?

T2 BIOSYSTEMS INC (TTOO) has a profitability rating of 0 / 10.


What is the financial health of T2 BIOSYSTEMS INC (TTOO) stock?

The financial health rating of T2 BIOSYSTEMS INC (TTOO) is 0 / 10.